Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial
Neal D. Shore, Christian Zurth, Robert E. Fricke et al. · Targeted Oncology · 2019
Cited by 90Open access